James N. Wilson, Director at CORCEPT THERAPEUTICS INC (CORT), sold 10,000 shares at $86.78 ($883K) on 2026-07-15, disclosed to the SEC on 2026-07-17.
Scheduled sale ($883k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $86.78 | 1,079 | $94K | 10.6% |
| 2 | $87.74 | 3,969 | $348K | 39.4% |
| 3 | $88.81 | 2,974 | $264K | 29.9% |
| 4 | $89.49 | 1,978 | $177K | 20.0% |
| Total | $88.30 avg | 10,000 | $883K | 100% |
| Filing → |
| CORT | SELL | 2026-06-18 | $832K | — | Filing → |
| CORT | SELL | 2016-11-14 | $1.4M | — | Filing → |
| CORT | SELL | 2016-01-06 | $6K | — | Filing → |